Vanderbilt Vaccine (VV) CRS [Site ID: 30352] — Nashville, Tennessee

Vanderbilt Vaccine (VV) CRS [Site ID: 30352] is a clinical research site located in Nashville, Tennessee, United States 37232-2582.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Vanderbilt Vaccine (VV) CRS [Site ID: 30352] has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hiv.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Vaccine (VV) CRS [Site ID: 30352]?

Vanderbilt Vaccine (VV) CRS [Site ID: 30352] has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Vaccine (VV) CRS [Site ID: 30352] conducted?

Vanderbilt Vaccine (VV) CRS [Site ID: 30352] has 1 clinical trials on record, with 1 currently active. Their work covers Hiv.

Is Vanderbilt Vaccine (VV) CRS [Site ID: 30352] accredited by Crixeo Clinical Trials?

Vanderbilt Vaccine (VV) CRS [Site ID: 30352] has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt Vaccine (VV) CRS [Site ID: 30352]?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.